Market research & opportunity assessment: Maintain voice-of-customer (VOC), total-available-market (TAM), serviceable-available-market (SAM), payer/clinical trends, relevant technology developments and the evolution of clinical practice/guidelines, and competitive intelligence for assigned products or segments, and synthesize these inputs into market assessments, customer segmentation (including share/Mekko analyses) and competitor strategies that shape segment strategy, product-line roadmaps, growth opportunities (including IVD partnership opportunities), portfolio gaps and rationalization options, and highlight risks across assigned systems, assays, quality controls and informatics. On-Market Lifecycle, Sustaining Prioritization & CAPA: Understand product performance (quality signals, complaints, cost-to-serve, usage, and mix) and recommend sustaining prioritization, including assay obsolescence and migration, contribute to corrective and preventive actions (CAPA), sustaining activities, and phase-in/phase-out and obsolescence decisions in order to protect customer experience and identify opportunities to improve portfolio productivity and profitability over time.